Skip to content
Methodology
All entries for: Kedrion S.p.A
July 25, 2025
Kedrion S.p.A
Orphan Drug Designation
FDA orphan drug designation: treatment of congenital aceruloplasminemia
Disease Area:
Rare Diseases
Source
Scroll to Top
